MedPath

Extra local pain relief in total knee arthroplasty

Conditions
ocal infiltration analgesia (LIA) a multimodal pain management strategy in total knee arthroplasty.This study will investigate the effect of LIA on postoperative pain, opiod consumption, length of hospital stay and adverse effects.By downscaling the LIA it's hypotised there will be less adverse effects and no differences in other endpoints.
Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Registration Number
EUCTR2012-001432-62-NL
Lead Sponsor
Reinier de Graaf Groep
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

The hospital criteria and protocol for patients who are diagnosed for a total knee arthroplasty in the outpatients’ clinic of the Orthopaedic Department of RdGG Hospital Delft
• Patients at least 18 years of age
• Scheduled for elective total knee arthroplasty
• ASA I-III
• Willing to participate
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 90

Exclusion Criteria

• age < 18
• ASA > III
• moderate or severe cardiac disease, bronchial asthma
• allergy against Ropivacain, Gabapentin
• pregnancy
• severe psychiatric disease
• moderate to severe dementia, mentally retarded
• BMI > 40
• Abuse alcohol and drugs
• Chronic use of opioids
• Patients diagnosed Rheumatoid arthritis
• Revision TKA

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath